Is vasoactive intestinal polypeptide (VIP) a sleep factor?
Vasoactive intestinal peptide (VIP) was tested in order to determine its hypnogenic properties in cats. VIP was administered intraventricularly in doses of 10 and 100 ng and compared to Ringer controls. In addition the dose of 100 ng was tested in cats pretreated with 150 mg/kg of chloramphenicol (CAP). The results showed that the 100 ng dose of VIP had small but significant REM enhancing properties, but that it did not protect the animals from the specific REM inhibiting properties of CAP. The results suggest that VIP may participate in the regulation of REM sleep.
D000818:Animals; D002415:Cats; D012890:Sleep / Q000187:drug effects*; D012895:Sleep, REM / Q000187:drug effects; D013997:Time Factors; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*; D014851:Wakefulness / Q000187:drug effects
D014660:Vasoactive Intestinal Peptide